Kitano Taito, Nishikawa Hiroki, Onaka Masayuki, Ishihara Mariko, Nishiyama Atsuko, Yoshida Sayaka
Neonatal Intensive Care Unit, Nara Prefecture General Medical Center, Nara, Japan.
Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
Pediatr Int. 2018 Apr;60(4):362-365. doi: 10.1111/ped.13502. Epub 2018 Feb 26.
Although the mumps vaccine has not been included in the national immunization program (NIP) in Japan, it has been shown that a two-dose routine vaccine program would be highly cost-effective. In this study, we carried outa questionnaire-based study to investigate how many Japanese parents want the mumps vaccine to be included in the NIP with proper information.
The questionnaire was given to parents who visited the Pediatrics or neonatal intensive care unit of Nara Prefecture General Medical Center, Nara City, Japan, between 1 March 2017 and 31 August 2017. The questionnaire consisted of information about mumps and six questions, for example (i) do parents know that mumps can be prevented by vaccine; (ii) do they know that they need to pay for mumps vaccines; and (iii) do they hope that the government will resume routine mumps vaccination.
In total, 1,224 parents answered the questionnaire. A total of 81% and 75.4% of parents knew that mumps can be prevented by vaccination and that mumps vaccine is not included in the NIP, respectively, before reading the information. After reading the information, 95.0% of parents thought that mumps vaccine should be included in the NIP. While 61.7% of parents answered that they would choose two-dose vaccination without governmental financial support, 92.1% of them would choose two-dose vaccination with governmental financial support (P < 0.0001).
Japanese parents want the mumps vaccine to be included in the NIP. Japan is able to start routine use of the mumps vaccine now.
尽管腮腺炎疫苗尚未被纳入日本的国家免疫规划（NIP），但已有研究表明，两剂常规疫苗接种计划具有很高的成本效益。在本研究中，我们开展了一项基于问卷调查的研究，以调查在获得适当信息后，有多少日本家长希望腮腺炎疫苗被纳入国家免疫规划。
问卷于2017年3月1日至2017年8月31日期间发放给前往日本奈良市奈良县综合医疗中心儿科或新生儿重症监护病房就诊的家长。问卷包括有关腮腺炎的信息以及六个问题，例如：（i）家长是否知道腮腺炎可以通过疫苗预防；（ii）他们是否知道需要自费接种腮腺炎疫苗；（iii）他们是否希望政府恢复常规腮腺炎疫苗接种。
共有1224名家长回答了问卷。在阅读信息之前，分别有81%和75.4%的家长知道腮腺炎可以通过接种疫苗预防以及腮腺炎疫苗未被纳入国家免疫规划。阅读信息后，95.0%的家长认为腮腺炎疫苗应被纳入国家免疫规划。虽然61.7%的家长回答在没有政府财政支持的情况下他们会选择两剂接种，但在有政府财政支持的情况下，92.1%的家长会选择两剂接种（P<0.0001）。
日本家长希望腮腺炎疫苗被纳入国家免疫规划。日本现在有能力开始常规使用腮腺炎疫苗。
